Pfizer is the industry's largest pharmaceutical R & D organization with estimated budget of $7.6 billion in research & development (R&D) to develop medicine of highest quality with over 13,000 researchers working for Pfizer Global Research and Development worldwide.

 

Pfizer's search for new treatments spans hundreds of research projects across 18 therapeutic areas - more than any other company. Our scientists, clinicians, technicians, and other professionals employ state-of-the-art tools ranging from robotic high-throughput screening (a method pioneered by Pfizer) to sophisticated genomic studies, to deliver a steady stream of innovative new products that enhance human and animal health.

 

Links with more than 250 partners in academia and industry strengthen our position on the cutting edge of science and biotechnology by providing access to novel R&D tools and to key data on emerging trends. A half century ago, despite daunting odds and great risk, Pfizer pioneered the mass production of penicillin, ushering in the modern pharmaceutical era. Now, more than 12,500 Pfizer scientists at our research facilities around the world continue the quest for new medicines with the same pioneering spirit.

 

Medical research department of Pfizer (Thailand ) Limited has participated in R & D for new medicines benefiting patients in Thailand . Previous research studies data from several medical institutions have been incorporated into current study experiments to further develop appropriate medicines for Thai population.

 

Until presently, Pfizer has collaborated with researchers from numerous medical institutions in more than 18 projects. The company has also participated in supporting the government in distributing knowledge about new research standards to medical personnel and practitioners on several occasions.

 

Pfizer has also partnered the Center of Disease Control (CDC) in conducting “Good Clinical Practice” training for research physicians and healthcare professionals involved in clinical research. More than 2,000 healthcare professionals have participated in this training each year since 2001.

 

Important objective for Medical research department at Pfizer is improving medical research and helping to support medical practitioners and researchers to achieve new technologies and standards in order to be acknowledged internationally for quality and benefits. As a result, this will be beneficial to every Thai citizen.